Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Prolight: SpinChip deal highlights the strategic importance and valuation potential of Prolight's solution - Emergers

Prolight Diagnostics

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
The recent acquisition of Norwegian point-of-care diagnostics platform SpinChip by bioMérieux for EUR 138 million underscores the growing interest, strategic importance and value potential of rapid in-vitro diagnostics. SpinChip’s acquisition value reflects a full takeover, which involves a higher risk for the buyer than licensing-in a technology, which is the path we base our fair value estimate of Prolight on. But applying a takeover scenario to our numbers would support a value of USD 150m, translating to SEK 2.1 per share, suggesting a significant premium to our fair value of SEK 0.9-1.0 per share.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team